SLU-PP-332 Capsules contain a synthetic small-molecule research compound intended exclusively for controlled laboratory investigation. SLU-PP-332 is used as a chemical research tool in studies examining estrogen-related receptor (ERR) activity, receptor-dependent transcription, and associated molecular signaling.
The capsule format represents the physical form in which the research material is supplied. It does not indicate suitability for ingestion, administration, or any other human or animal application.
SLU-PP-332 is not a peptide, drug, dietary supplement, food, cosmetic, or therapeutic product. No dosing, administration, or application guidance is provided.
The chemical identity of SLU-PP-332 is listed by PubChem as C₁₈H₁₄N₂O₂, with a molecular weight of approximately 290.32 g/mol and CAS Registry Number 303760-60-3.
Nordsci provides lot-specific analytical documentation to support compound identification, quality review, and laboratory traceability. Researchers should consult the Certificate of Analysis associated with the applicable lot before beginning an experiment.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
SLU-PP-332 Capsules contain a synthetic small-molecule compound supplied exclusively for controlled laboratory research. Published nonclinical research has characterized SLU-PP-332 as an agonist of the estrogen-related receptors ERRα, ERRβ, and ERRγ.
Laboratory investigators may use SLU-PP-332 as a chemical probe when examining receptor activation, receptor-dependent transcription, compound-target interactions, and ERR-associated molecular signaling. Results obtained from cell-based assays or other nonclinical models must remain limited to the conditions and methodology of the experiment.
The capsule presentation describes the physical format in which the research material is supplied. It does not indicate suitability for ingestion, administration, or any human or animal application. SLU-PP-332 Capsules are not drugs, dietary supplements, foods, cosmetics, or therapeutic products.
SLU-PP-332 Capsules – Research Specifications:
| Compound Name | SLU-PP-332 |
| Chemical Classification | Synthetic small molecule |
| Chemical Name | 4-hydroxy-N-[(E)-naphthalen-2-ylmethylideneamino]benzamide |
| Molecular Formula | C₁₈H₁₄N₂O₂ |
| Molecular Weight | Approximately 290.32 g/mol |
| CAS Number | 303760-60-3 |
| Sequence | Not applicable; SLU-PP-332 is not a peptide |
| Physical Form | Encapsulated research compound |
| Purity and Identity | Refer to the lot-specific Certificate of Analysis for reported analytical findings |
| Storage Conditions | Keep sealed and follow the storage instructions provided on the product label and applicable Certificate of Analysis |
| Research Restrictions | Not for human or animal consumption, in-vivo procedures, clinical use, or veterinary use |
SLU-PP-332 is a synthetic research compound associated with the laboratory study of estrogen-related receptors. ERRs are nuclear receptors examined in molecular biology because of their involvement in receptor-dependent gene transcription.
Published nonclinical research has characterized SLU-PP-332 as an ERRα/β/γ agonist with comparatively greater reported activity at ERRα. Controlled experiments may use the compound to examine ERR activation, receptor-subtype selectivity, downstream transcriptional responses, and the relationship between receptor activity and observed assay results.
References to published research identify the compound’s experimental background only. They do not establish an approved application or provide evidence of safety, effectiveness, or suitability for human or animal use.
Important Research Notice: Nordsci provides lot-specific analytical documentation when available. Researchers should review the Certificate of Analysis associated with the received lot to confirm reported identity, purity, analytical methods, and other applicable findings.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR IN-VIVO PROCEDURES. NOT INTENDED FOR DIAGNOSTIC, THERAPEUTIC, VETERINARY, FOOD, DRUG, COSMETIC, OR SUPPLEMENT USE.
SLU-PP-332 may be used in controlled laboratory assays designed to characterize the activation of estrogen-related receptors. Investigators should establish defined experimental conditions, validated endpoints, and appropriate controls before conducting an assay.
This research context does not indicate a consumer, nutritional, performance, or therapeutic application.
Laboratory experiments may compare the compound’s activity across ERRα, ERRβ, and ERRγ. These studies can examine receptor selectivity, concentration-dependent assay responses, and differences between receptor subtypes within a defined experimental system.
Findings must be interpreted according to the limitations of the selected assay, model, controls, and analytical methodology.
Cell-based research may examine transcriptional changes associated with ERR activation under controlled laboratory conditions. Appropriate positive, negative, and vehicle controls are necessary to distinguish compound-associated observations from background or model-specific variation.
Experimental findings must not be extrapolated into claims concerning human or animal outcomes.
Researchers may use SLU-PP-332 when investigating compound-target interactions and ERR-dependent signaling. Experimental design should account for compound concentration, assay duration, solvent compatibility, sample preparation, equipment calibration, and model selection.
No diagnostic, therapeutic, veterinary, or clinical application is represented or implied.
SLU-PP-332 Capsules should be handled only by qualified laboratory personnel following procedures appropriate for chemical research materials. Before handling the compound, researchers should review the product label, applicable safety documentation, institutional protocols, and lot-specific Certificate of Analysis.
The material must not be administered to humans or animals. It is not intended for veterinary procedures, diagnostic testing, therapeutic applications, food production, cosmetic formulation, or supplement development.
Protocol Design Considerations: Experimental findings may be affected by compound concentration, solvent compatibility, assay conditions, sample preparation, exposure duration, equipment calibration, environmental conditions, and the selected analytical or biological model. Researchers are responsible for developing validated procedures and selecting suitable positive, negative, and vehicle controls.
Note: This information is provided exclusively as a laboratory research reference. It does not constitute dosing, administration, clinical, veterinary, or medical guidance.
Lot-specific Certificates of Analysis are provided to facilitate laboratory review, compound identification, quality assessment, and material traceability. Depending on the documentation available for the applicable lot, the COA may include:
Researchers should rely on the Certificate of Analysis associated with the received lot rather than generalized product-page information. Analytical documentation does not indicate approval for human consumption, animal consumption, in-vivo procedures, diagnostic use, or therapeutic use.
Nordsci supplies SLU-PP-332 Capsules exclusively as a research-use-only laboratory material. Ordering is limited to purchasers who understand and accept the applicable research restrictions.
Product availability does not indicate that SLU-PP-332 has been approved, evaluated, or manufactured for human or animal consumption. Purchasers are responsible for complying with all applicable institutional, local, state, federal, and international requirements.
IMPORTANT: SLU-PP-332 Capsules are supplied exclusively for laboratory research use. They are not approved for human consumption, animal consumption, in-vivo procedures, veterinary use, diagnostic use, or therapeutic use. No dosing, administration, or application instructions are provided.
Scientific references describe controlled experimental research and do not establish safety, effectiveness, approval, or suitability for human or animal use.
